October 31, 2024

Invitation to presentation of the Q3 report 2024

Oncopeptides AB published the report for the third quarter of 2024, at 08:00 CET on November 7, 2024. Investors, financial analysts, and media are invited to participate in a webcast and a subsequent Q&A session, at 10:00 CET on same day.

The presentation will be hosted by Sofia Heigis, CEO, together with Henrik Bergentoft, CFO. The webcast will be held in English and published below in conjunction with the start of the presentation.

Information for participants

If you wish to participate via webcast please use the link below.
https://ir.financialhearings.com/oncopeptides-q3-report-2024

If you wish to participate via teleconference please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference.
https://conference.financialhearings.com/teleconference/?id=50048827

Webcast presentation as PDF file